SOIBD Collagenous Colitis Maintenance Study

NCT01278082 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Induction and Maintaining Remission of Collagenous Colitis

Interventions

DRUG: Budesonide
DRUG: Placebo

Sponsor

Dr. Falk Pharma GmbH

Collaborators

[object Object]